Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children

被引:9
作者
Nelson, MR
Kardia, SLR
Ferrell, RE
Sing, CF
机构
[1] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[3] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA
关键词
D O I
10.1046/j.1469-1809.1999.6340311.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The impact of the three most common apolipoprotein E (APOE) genotypes (epsilon 32, epsilon 33, and epsilon 43) on means, variances, and correlations of nine plasma lipid and apolipoprotein traits (total cholesterol, lnTriglycerides, HDL cholesterol, and apolipoproteins AI, AII, B, CII, CIII, and lnE) was studied in 212 unrelated female and 219 unrelated male children aged 5-21.5 years from 278 pedigrees ascertained without regard to health status from Rochester, Minnesota. There was significant heterogeneity (p less than or equal to 0.05) among genotypes for the mean plasma levels of lnApo E, Apo CII; Apo CIII, and lnTriglycerides (lnTrig) in females, and for the means of lnApo E, Apo B, and total cholesterol (Total-C) in males. Significant heterogeneity of intragenotypic variance was observed in males for Apo CII, lnTrig, and HDL-C; no significant heterogeneity was observed in females. Pairwise correlations between traits differed significantly among APOE genotypes in both females (6 of 36 pairs) and males (5 of 36 pairs). These results differ from those obtained from studies of the parental generation from the same sample of pedigrees. Our study further demonstrates that, with the exception of mean lnApo E levels, the univariate and bivariate distributions of traits that are measures of lipoprotein metabolism are influenced by variation in the APOE gene in a gender- and generation-dependent manner.
引用
收藏
页码:311 / 328
页数:18
相关论文
共 58 条
[1]   CARDIOVASCULAR RISK IN YOUNG FINNS [J].
AKERBLOM, HK ;
UHARI, M ;
PESONEN, E ;
DAHL, M ;
KAPRIO, EA ;
NUUTINEN, EM ;
PIETIKAINEN, M ;
SALO, MK ;
AROMAA, A ;
KANNAS, L ;
KELTIKANGASJARVINEN, L ;
KUUSELA, V ;
RASANEN, L ;
RONNEMAA, T ;
KNIP, M ;
TELAMA, R ;
VALIMAKI, I ;
PYORALA, K ;
VIIKARI, J .
ANNALS OF MEDICINE, 1991, 23 (01) :35-39
[2]  
*AM HEART ASS, 1998, 1998 HEART STROK STA
[3]   JOINT LIPID RISK-FACTORS AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
CIRCULATION, 1992, 85 (01) :365-367
[4]  
BADIMON JJ, 1993, CIRCULATION, V87, P3
[5]   Lessons from metabolic engineering for functional genomics and drug discovery [J].
Bailey, JE .
NATURE BIOTECHNOLOGY, 1999, 17 (07) :616-618
[6]  
Bar-Yam Y., 1997, Dynamics of complex systems, V213
[7]   IMPROVED COLOR REAGENT FOR DETERMINATION OF BLOOD-GLUCOSE BY OXIDASE SYSTEM [J].
BARHAM, D ;
TRINDER, P .
ANALYST, 1972, 97 (1151) :142-&
[8]  
BARR SI, 1981, CLIN CHEM, V27, P1142
[10]  
Berenson GS, 1980, CARDIOVASCULAR RISK